Societal expectations can create barriers that prevent men from seeking out the mental, physical, and sexual help they need. Clinicians can help break these down.

Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

The expanded services help customers receive consultations and medications for erectile dysfunction, men’s hair loss, eyelash growth, motion sickness, and anti-aging skin care.

BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN ...

Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment ...

Shares of Hims & Hers ($HIMS) plummeted nearly 15% on Thursday after Amazon.com, Inc. ($AMZN) launched its new Amazon One ...

Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and ...

Shares of Hims&Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty ...